Literature DB >> 10716610

Influence of extracellular K+ concentrations on quinidine-induced K+ current inhibition in rat ventricular myocytes.

M Hirota1, H Ohtani, E Hanada, H Sato, H Kotaki, H Uemura, H Nakaya, T Iga.   

Abstract

Hypokalaemia is one of the important risk factors for development of torsades de pointes. We recently reported that hypokalaemia increased the electrocardiographic QT interval in rats treated with quinidine, but did not alter the arrhythmogenic potency of quinidine. In this study, we have investigated the influence of extracellular potassium concentration ([K+]o) on the inhibition of several types of cardiac potassium currents by quinidine. Such types of currents include the delayed rectifier potassium current (I(K)), the transient outward current (Ito), and the inward rectifier potassium current (I(K1)), as measured in isolated rat ventricular cells using patch-clamp techniques. Concentration-dependent effects of quinidine on I(K), Ito, and I(K1) were evaluated under both normal ([K+]o = 5.4 mM) and hypokalaemic ([K+]o = 3.5 mM) conditions. In contrast to both I(K) and Ito, which were barely influenced by changes in [K+]o, I(K1) was significantly inhibited by hypokalaemia. Furthermore, while quinidine suppressed both I(K) and Ito in a concentration-dependent manner, the inhibitory potency of quinidine on these currents was not influenced by changes in [K+]o. The respective normal and hypokalaemic IC50 values for quinidine were 11.4 and 10.0 microM (I(K)), and 17.6 and 17.3 microM (Ito). Although higher concentrations of quinidine were required to inhibit I(K1), the inhibitory potency of quinidine was also found to be insensitive to changes in [K+]o. Thus, in rats, the inhibitory potency of quinidine for the K+ current-types I(K), Ito and I(K1) is barely influenced by changes in [K+]o. These findings are consistent with our previous report showing that the QT-prolonging potency of quinidine was not altered under hypokalaemic conditions. However, whilst hypokalaemia does not affect I(K) or Ito, it can inhibit I(K1) and can result in QT prolongation in-vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716610     DOI: 10.1211/0022357001773571

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels.

Authors:  Ingo Staudacher; Claudius Illg; Sam Chai; Isabelle Deschenes; Sebastian Seehausen; Dominik Gramlich; Mara Elena Müller; Teresa Wieder; Ann-Kathrin Rahm; Christina Mayer; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-14       Impact factor: 3.000

2.  Electrophysiologic effects of the IK1 inhibitor PA-6 are modulated by extracellular potassium in isolated guinea pig hearts.

Authors:  Gregory S Hoeker; Mark A Skarsfeldt; Thomas Jespersen; Steven Poelzing
Journal:  Physiol Rep       Date:  2017-01-13

3.  Electrical storm reversible by isoproterenol infusion in a striking case of early repolarization.

Authors:  Anne Bernard; Olivier Genée; Caroline Grimard; Frédéric Sacher; Laurent Fauchier; Dominique Babuty
Journal:  J Interv Card Electrophysiol       Date:  2009-01-19       Impact factor: 1.900

4.  Changes in Serum Electrolytes, ECG, and Baroreflex Sensitivity during Combined Pituitary Stimulation Test.

Authors:  Sungsu Kim; Choong Hwan Kwak; Jaehoon Jung; Jong Ha Baek; Jung Hwa Jung; Ki-Jong Park; Kyongyoung Kim; Soo Kyoung Kim; Dawon Kang; Jong Ryeal Hahm
Journal:  Biomed Res Int       Date:  2018-05-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.